CYNTHIA A SANCHEZ
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LOS ANGELES, CA NPI 1902089337
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$1,205.51
- Category: General Payments
- Program years: PY2021–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $509.56 across 5 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $509.56 | 5 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $236.33 | 2 |
| ARGENX US, INC. | $120.60 | 1 |
| Novo Nordisk AS | $120.39 | 1 |
| REVANCE THERAPEUTICS, INC. | $32.24 | 1 |
By program year
Records — PY2024 (5)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100365681 | Novo Nordisk Inc | $120.39 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142151925 | ARGENX US, INC. | $120.60 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147950332 | REVANCE THERAPEUTICS, INC. | $32.24 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150920270 | Neurocrine Biosciences, Inc. | $126.44 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150924726 | Neurocrine Biosciences, Inc. | $109.89 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.